From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations

Tamires Ferreira da Silva1,2, Juscelino Carvalho de Azevedo1,2, Eliel Barbosa Teixeira2

  • 1Programa de Residência Multiprofissional em Saúde (Oncologia), Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém, Brazil.

PubMed

Insights

Next-generation sequencing (NGS) advances circulating tumor DNA (ctDNA) analysis for precision medicine. This review explores NGS methods for ctDNA mutation detection, addressing challenges for clinical application.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Precision medicine relies on identifying cancer-associated gene mutations for targeted therapies.
  • Circulating tumor DNA (ctDNA) analysis in blood provides insights for early cancer detection, treatment monitoring, and surveillance.
  • Detecting low-frequency mutations in ctDNA requires highly sensitive analytical techniques.

Purpose of the Study:

  • To review Next-Generation Sequencing (NGS) approaches for ctDNA mutation identification.
  • To discuss the challenges and considerations for implementing NGS in clinical ctDNA analysis.

Main Methods:

  • Review of current Next-Generation Sequencing (NGS) technologies, including parallel and long-read sequencing.
  • Analysis of different NGS strategies applied to circulating tumor DNA (ctDNA) mutation detection.

Main Results:

  • NGS technology, particularly with advancements in long-read capabilities, improves the sensitivity of ctDNA mutation analysis.
  • Various NGS approaches exist, each with specific strengths and limitations for ctDNA analysis.

Conclusions:

  • Optimal application of NGS for ctDNA mutation analysis requires addressing challenges in standardization, cost, specificity, and bioinformatics.
  • Standardized NGS methodologies are crucial for reliable ctDNA mutation detection to guide precision cancer medicine.

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.5K
Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
753.9K
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.9K